USD 65.17
(0.11%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 | 921.7 Million CHF | -5.82% |
2023 | 978.7 Million CHF | 0.53% |
2022 | 960.9 Million CHF | 31.89% |
2021 | 755.3 Million CHF | 6.23% |
2020 | 711 Million CHF | 7.08% |
2019 | 659.6 Million CHF | 8.99% |
2018 | 615.5 Million CHF | 5.76% |
2017 | 566.46 Million CHF | 18.66% |
2016 | 487.27 Million CHF | -4.48% |
2015 | 508.22 Million CHF | 4.72% |
2014 | 485.31 Million CHF | 105.61% |
2013 | 236.03 Million CHF | -36.8% |
2012 | 366.06 Million CHF | -16.01% |
2011 | 409.15 Million CHF | -42.45% |
2010 | 616.14 Million CHF | 107.79% |
2009 | 371.86 Million CHF | 0.05% |
2008 | 371.68 Million CHF | 16.22% |
2007 | 319.82 Million CHF | 31.25% |
2006 | 244.84 Million CHF | 57.83% |
2005 | 153.61 Million CHF | 62.95% |
2004 | 94.74 Million CHF | 359.69% |
2003 | -36.48 Million CHF | -161.01% |
2002 | 59.8 Million CHF | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 437.7 Million CHF | -15.17% |
2024 FY | - CHF | -6.1% |
2024 Q4 | 392.7 Million CHF | -10.28% |
2023 Q2 | 485.5 Million CHF | -5.05% |
2023 Q4 | 516 Million CHF | 6.28% |
2023 FY | - CHF | 0.53% |
2022 Q4 | 511.3 Million CHF | 5.44% |
2022 FY | - CHF | 31.89% |
2022 Q2 | 484.9 Million CHF | -4.02% |
2021 FY | - CHF | 6.23% |
2021 Q2 | 250.1 Million CHF | -36.31% |
2021 Q4 | 505.2 Million CHF | 102.0% |
2020 Q4 | 392.7 Million CHF | 14.93% |
2020 FY | - CHF | 7.08% |
2020 Q2 | 341.7 Million CHF | -5.53% |
2019 Q2 | 291.2 Million CHF | -13.56% |
2019 Q4 | 361.7 Million CHF | 24.21% |
2019 FY | - CHF | 8.99% |
2018 Q4 | 336.88 Million CHF | 24.58% |
2018 Q2 | 270.41 Million CHF | -5.11% |
2018 FY | - CHF | 5.76% |
2017 FY | - CHF | 18.66% |
2017 Q4 | 284.97 Million CHF | 20.11% |
2017 Q2 | 237.25 Million CHF | -4.9% |
2016 Q2 | 213.14 Million CHF | -16.4% |
2016 FY | - CHF | -4.48% |
2016 Q4 | 249.49 Million CHF | 17.05% |
2015 Q2 | 240.77 Million CHF | 0.55% |
2015 FY | - CHF | 4.72% |
2015 Q4 | 254.96 Million CHF | 5.89% |
2014 Q4 | 239.45 Million CHF | 2.05% |
2014 Q2 | 234.64 Million CHF | 9.46% |
2014 FY | - CHF | 105.61% |
2013 Q4 | 214.36 Million CHF | 0.0% |
2013 FY | - CHF | -36.8% |
2013 Q2 | - CHF | 0.0% |
2012 Q2 | - CHF | 0.0% |
2012 FY | - CHF | -16.01% |
2011 Q2 | - CHF | 0.0% |
2011 FY | - CHF | -42.45% |
2010 FY | - CHF | 107.79% |
2009 FY | - CHF | 0.05% |
2008 FY | - CHF | 16.22% |
2007 FY | - CHF | 31.25% |
2006 FY | - CHF | 57.83% |
2005 FY | - CHF | 62.95% |
2004 FY | - CHF | 359.69% |
2003 FY | - CHF | -161.01% |
2002 FY | - CHF | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
AVITA Medical, Inc. | -39.56 Million USD | 2429.422% |
Manhattan Scientifics, Inc. | -1.16 Million USD | 79283.849% |
Össur hf. | 137.38 Million USD | -570.908% |
QHSLab, Inc. | -91.29 Thousand USD | 1009706.432% |
Wellstar International, Inc. | -1.35 Million USD | 68046.021% |
Össur hf. | 137.38 Million USD | -570.908% |
CVR Medical Corp. | - USD | -Infinity% |
Bionovate Technologies Corp | - USD | -Infinity% |
Escalon Medical Corp. | -58.46 Thousand USD | 1576706.627% |
Aurora Spine Corporation | -454.37 Thousand USD | 202948.729% |
BrainsWay Ltd. | -2.31 Million USD | 39983.167% |
Lattice Biologics Ltd. | - USD | -Infinity% |
BioElectronics Corporation | -274.29 Thousand USD | 336131.208% |
Hamilton Thorne Ltd. | 5.52 Million USD | -16592.55% |
Vivos Inc. | -2.79 Million USD | 33098.633% |
Kelyniam Global, Inc. | -197.69 Thousand USD | 466332.656% |
REMSleep Holdings, Inc. | -1.66 Million USD | 55339.447% |
Zecotek Photonics Inc. | -3.44 Million USD | 26876.332% |
Avitar, Inc. | -1.66 Million USD | 55364.321% |
Nanomix Corporation | -8.13 Million USD | 11423.42% |
EKF Diagnostics Holdings plc | 9.77 Million USD | -9330.031% |
Theraclion SA | -2.05 Million USD | 45043.744% |
Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
Positron Corporation | -1.45 Million USD | 63571.361% |
Rafina Innovations Inc. | - USD | -Infinity% |
Electromedical Technologies, Inc. | -1.72 Million USD | 53628.546% |
Lombard Medical, Inc. | -28.06 Million USD | 3383.811% |
ALR Technologies Inc. | -6.4 Million USD | 14500.854% |
Stratec SE | 39.91 Million USD | -2209.215% |
Vycor Medical, Inc. | 100.94 Thousand USD | -912989.565% |
Heart Tronics, Inc. | -14.85 Million USD | 6303.861% |
MicroPort Scientific Corporation | -347.57 Million USD | 365.178% |
VMS Rehab Systems, Inc. | -68.55 USD | 1344566110.212% |
NewCardio, Inc. | -9.37 Million USD | 9926.931% |
Guided Therapeutics, Inc. | -3.12 Million USD | 29584.965% |
Ingen Technologies, Inc. | -8639.00 USD | 10669158.919% |
Odyssey Group International, Inc. | -2.13 Million USD | 43208.891% |
CYduct Diagnostics, Inc. | -378.9 Thousand USD | 243352.944% |
Wellness Center USA, Inc. | -707.03 Thousand USD | 130462.219% |
SANUWAVE Health, Inc. | -9.15 Million USD | 10171.024% |
IR-Med Inc. | -4.89 Million USD | 18940.965% |
Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 7042.16% |
Polarean Imaging plc | -11.19 Million USD | 8333.146% |
United American Healthcare Corporation | -59 Thousand USD | 1562303.39% |
ECGI Holdings, Inc. | -2.99 Million USD | 30921.634% |
Nu-Med Plus, Inc. | -118.25 Thousand USD | 779490.998% |
Capital Group Holdings, Inc. | -629.18 Thousand USD | 146591.561% |
ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | 179410.345% |
Medical Supply International USA, Inc. | 456.06 Thousand USD | -202000.601% |
Urologix, Inc. | -6.34 Million USD | 14628.689% |
Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | 74468.969% |
Nexeon MedSystems Inc. | -765.96 Thousand USD | 120431.555% |
SS Innovations International, Inc. | -20.37 Million USD | 4623.461% |
Qualis Innovations, Inc. | -222.81 Thousand USD | 413755.988% |
Smith & Nephew plc | 1 Billion USD | 8.068% |
NIOX Group Plc | 11.07 Million USD | -8222.272% |
Fuse Medical, Inc. | 1.83 Million USD | -50120.235% |
Broncus Holding Corporation | -25.19 Million USD | 3757.712% |
Brain Scientific Inc. | -7.93 Million USD | 11717.492% |
Pressure BioSciences, Inc. | -9.39 Million USD | 9914.817% |
Health Logic Interactive Inc. | -18.4 Thousand USD | 5009339.13% |